相关实验视频
Updated: Jul 26, 2025
13:07
A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
12.2K
强光疗法对双极性抑郁症刺激性的影响:单盲随机对照试验
Lorenzo Fregna1, Francesco Attanasio2, Cristina Colombo1,2
1Department of Clinical Neurosciences, Mood Disorder Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
International journal of psychiatry in clinical practice
|June 12, 2023
概括
强光疗法 (BLT) 显著降低了双极性抑郁症患者的易怒性. 这一发现表明,BLT是一种有用的辅助治疗,用于控制易怒,即使没有完全缓解抑郁症.
科学领域:
- 精神病学是一个精神病学.
- 情绪障碍 情绪障碍 情绪障碍
- 治疗干预 治疗干预
背景情况:
- 易怒是双极性抑郁症的常见和有害症状,影响治疗的坚持,增加暴力和自杀的风险.
- 尽管它很常见,但双极性抑郁症中的易怒性得到了有限的科学关注.
- 了解有效的刺激性治疗方法对于改善患者的治疗结果至关重要.
研究的目的:
- 评估明亮光疗法 (BLT) 作为双极性抑郁症患者易怒的潜在治疗方法.
- 进行第一个随机对照试验,研究BLT对这种特定症状复合物的研究.
主要方法:
- 一项随机对照试验,涉及180名患有双极性抑郁症的住院患者.
- 参与者被分配到每天的明亮光疗法 (BLT) 或单独的药物治疗,持续4周.
- 在治疗期间后,对易怒性进行了定性评估.
主要成果:
- 与仅接受药物治疗的小组相比,接受BLT的小组表现出约三分之一的易怒症病例.
- 这种刺激性降低观察到独立于整体抑郁症状缓解.
- BLT显示对易怒症状有特定影响.
结论:
- 这项研究提供了证据,支持明亮光疗法 (BLT) 治疗双极性抑郁症情绪易怒的有效性.
- 在这种患者群体中,BLT可以作为一种有价值的治疗策略来解决易怒症.
- 进一步的研究可以探索双极性抑郁症的最佳BLT协议.
相关概念视频
01:30Bipolar Disorder
109
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
109
01:24Mania and Antimanic Drugs: Overview
254
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
254
01:30Electroconvulsive Therapy
77
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
77
01:27Depressive Disorders: MDD and Dysthymia
177
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
177
01:25Interpersonal Psychotherapy
61
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
61
01:23Antidepressant Drugs: MAOIs and Other Agents
280
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
280